A RELIABILITY STUDY OF SLEDAI - A DISEASE-ACTIVITY INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：0
|
作者：
HAWKER, G
GABRIEL, S
BOMBARDIER, C
GOLDSMITH, C
CARON, D
GLADMAN, D
机构：
[1] WELLESLEY COLL HOSP, DEPT MED, DIV RHEUMATOL, TORONTO M4Y 1J3, ONTARIO, CANADA
[2] MAYO CLIN & MAYO FDN, DEPT MED, DIV RHEUMATOL, ROCHESTER, MN 55905 USA
[3] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON L8S 4L8, ONTARIO, CANADA
[4] WELLESLEY COLL HOSP, CLIN EPIDEMIOL UNIT, TORONTO M4Y 1J3, ONTARIO, CANADA
来源：
JOURNAL OF RHEUMATOLOGY | 1993年 / 20卷 / 04期
关键词：
LUPUS DISEASE ACTIVITY; SLEDAI; OUTCOME MEASURES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SLEDAI, a disease activity index for systemic lupus erythematosus (SLE) has been validated against other such indices and its reliability has been shown by specialists in SLE. To assess its reliability among less experienced clinicians, we conducted a reliability study 3 rheumatology trainees and 9 patients with SLE according to a Latin square design. SLEDAI easily distinguished between patients (p = 0.0009), and physician variability was not statistically significant (p = 0.27). Inter and intraobserver agreement were 78.7 and 98.0%, respectively. SLEDAI was thus shown to be a reliable instrument among less experienced observers for the assessment of disease activity in SLE.
引用
收藏
页码：657 / 660
页数：4
相关论文
共 50 条
  • [1] HYPERPROLACTINEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH DISEASE-ACTIVITY
    JARA, LJ
    GOMEZSANCHEZ, C
    SILVEIRA, LH
    MARTINEZOSUNA, P
    VASEY, FB
    ESPINOZA, LR
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (04): : 222 - 226
  • [2] FIBROMYALGIA SYNDROME AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    MORAND, EF
    MILLER, MH
    WHITTINGHAM, S
    LITTLEJOHN, GO
    LUPUS, 1994, 3 (03) : 187 - 191
  • [3] RETINOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATIONSHIP TO DISEASE-ACTIVITY
    KLINKHOFF, AV
    BEATTIE, CW
    CHALMERS, A
    ARTHRITIS AND RHEUMATISM, 1986, 29 (09): : 1152 - 1156
  • [4] SEROLOGICAL MARKERS OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SPRONK, PE
    LIMBURG, PC
    KALLENBERG, CGM
    LUPUS, 1995, 4 (02) : 86 - 94
  • [5] CRITERIA FOR ASSESSING DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ISENBERG, D
    BACON, P
    BOMBARDIER, C
    GLADMAN, D
    GOLDSMITH, CH
    KALUNIAN, K
    LIANG, M
    MADDISON, P
    NIVED, O
    RICHTER, M
    SNAITH, M
    SYMMONS, D
    UROWITZ, M
    ZOMA, A
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (10) : 1395 - 1396
  • [6] PROLACTIN - A STIMULATOR OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    WALKER, SE
    ALLEN, SH
    HOFFMAN, RW
    MCMURRAY, RW
    LUPUS, 1995, 4 (01) : 3 - 9
  • [7] THE LUPUS BAND TEST AS A MEASURE OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    HALBERG, P
    ULLMAN, S
    JORGENSEN, F
    ARCHIVES OF DERMATOLOGY, 1982, 118 (08) : 572 - 576
  • [8] ACUTE REVERSIBLE HYPOXEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A NEW SYNDROME OR AN INDEX OF DISEASE-ACTIVITY
    MARTINEZTABOADA, VM
    BLANCO, R
    ARMONA, J
    FERNANDEZSUEIRO, JL
    RODRIGUEZVALVERDE, V
    LUPUS, 1995, 4 (04) : 259 - 262
  • [9] VALIDITY OF RETROSPECTIVE DISEASE-ACTIVITY ASSESSMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ARCESALINAS, A
    CARDIEL, MH
    GUZMAN, J
    ALCOCERVARELA, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 417 - 417
  • [10] THE RELATIONSHIP OF ANTICARDIOLIPIN ANTIBODIES TO DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    COOPER, RC
    KLEMP, P
    STIPP, CJ
    BRINK, S
    BRITISH JOURNAL OF RHEUMATOLOGY, 1989, 28 (05): : 379 - 382
12345